Skip to content

Clinical trials

Phase 3 Coronary Disease trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Disease Phase: Phase 3 Country / region: United Kingdom Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20062
20071
20082
20092
20101
20112
20121
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche3
GlaxoSmithKline2
University of Oxford2
Amgen1
Cordis US Corp.1
Institut de Recherches Internationales Servier1
Kastle Therapeutics, LLC1
National Heart and Lung Institute1
Pfizer1
Royal Sussex County Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Disease15
Cardiovascular Diseases5
Atherosclerosis2
Diabetes Mellitus2
Heart Diseases2
Peripheral Arterial Disease2
Stroke2
Acute Coronary Syndrome1
Angina Pectoris1
Dyslipidemias1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.